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ABSTRACT
Sparganosis is caused by a larval tapeworm of the genus Spirometra, which commonly invades subcutaneous tissue, but less 
frequently invades muscle, intestines, spinal cord, and the peritoneopleural cavity. The authors managed a female patient 
who presented with a recurrent pericardiopleural effusion and peripheral eosinophilia. The anti-sparganum-specific IgG se-
rum level was significantly higher than normal control levels. In this patient, sparganosis was caused by the ingestion of raw 
frogs in an effort to control her thyroid disease. The recurrent pericardiopleural effusion and peripheral eosinophilia were 
controlled by 3 consecutive doses of praziquantel (75 mg/kg/day). The patient is doing well 4 years after presentation. Spar-
ganosis should be considered a rare, but possible cause of recurrent pericardial effusion and peripheral eosinophilia. Immu-
noserologic testing using enzyme linked immunosorbent assays can be helpful in diagnosing human sparganosis, especially 
in cases without a subcutaneous lump or mass. Praziquantel is an alternative treatment for sparganosis in surgically-unre-
sectable cases. (Korean Circ J 2011;41:38-42)
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Introduction
Sparganosis is an infectious disease caused by the plero-
cercoid larvae of various diphyllobothroid tapeworms of the 
genus Spirometra, such as S. mansoni, S. mansonoides, S. eri-
nacei, S. ranarum, S. decipiens, S. houghtoni, and S. prolife-
rum.
1)2) The common clinical manifestation of sparganosis is 
a subcutaneous lump or mass in the abdominal wall, scrotum, 
lower extremity, or chest wall. The sparganum can invade 
muscle, intestines, breast tissue, eyes, spinal cord, and rarely, 
the peritoneopleural cavity.
3) Pleural effusions related to spar-
ganosis have been reported in but a few cases.
4-10) 
Pericardial effusions are not uncommonly encountered in 
daily clinical practice as the cause of chest discomfort, dys-
pnea, and sudden hypotension. Diagnostic pericardiocente-
sis is frequently used to analyze the characteristics of peri-
cardial fluid, and exudative or bloody pericardial effusions 
obtained during diagnostic pericardiocentesis should be studi-
ed meticulously using laboratory examinations and imaging 
modalities to define the cause of the pericardial effusion, which 
includes malignancies, uremia, large vessel trauma, or infec-
tions related to bacteria, viruses, or mycobacteria. Sometimes, 
surgical pericardiectomy and biopsy is essential to determine 
the cause of a pericardial effusion.
11)12) In addition, a special di-
agnostic tool, such as an enzyme linked immunosorbent as-
say (ELISA) is necessary to diagnose sparganosis. Herein we re-
port a rare form of human sparganosis that presented with a 
recurrent pericardiopleural effusion and peripheral eosinoph-
ilia without a subcutaneous mass or lump. 
Case
A 53-year-old woman sought evaluation in our cardiology 
outpatient clinic to for chest pain that persisted for 2 weeks in 
June 2005. The chest pain was described as “prickly,” triggered Ju-Hee Lee, et al.   39
mainly by deep inspiration, and unrelated to exercise. The pa-
tient also complained of a dry cough, arthralgias, generalized 
malaise, and a chilling sensation. She had taken medications 
for diabetes, hypertension, and hypothyroidism for 10 years. 
Her vital signs were as follows: blood pressure, 120/80 mmHg; 
heart rate, 130/minute; respiratory rate, 20/minute; and body 
temperature, 36.5°C. The initial laboratory test results were 
as follows: white blood cell (WBC) count, 10,800/μL with 
26.9% eosinophils; erythrocyte sedimentation rate, 32 mm/
hour; C-reactive protein level, 2.60 mg/dL; blood urea nitro-
gen, 15 mg/dL; serum creatinine, 0.9 mg/dL; total calcium, 
9.6 mg/dL; phosphate, 4.0 mg/dL; alanine aminotransferase, 
26 IU/L; aspartate aminotransferase, 16 IU/L; total bilirubin, 
0.2 mg/dL; thyroid stimulating hormone, 0.75 μIU/mL; free 
thyroxine, 1.37 ng/dL; and total triiodothyronine, 63.80 ng/dL 
(n.b., the thyroid function tests were within normal limits be-
cause she had taken levothyroxine on a regular basis). Chest 
radiography showed mild cardiomegaly and a blunted left 
costophrenic angle without pulmonary congestion (Fig. 1A). 
Electrocardiography (ECG) showed atrial fibrillation with a 
rapid ventricular response, whereas normal sinus rhythm had 
been observed in a local clinic 2 weeks previously. Echocar-
diography demonstrated a pericardial effusion of maximal 
depth 12 mm, without hemodynamic significance (Fig. 1B 
and C). Chest computed tomography (CT) also showed a 
significant amount of pericardial effusion and a minimal am-
ount of pleural effusion without nodular densities on the pleu-
ra or pericardium (Fig. 1D). The amounts of pericardial and pl-
eural effusion were too small to perform a percutaneous ne-
edle aspiration to obtain a fluid sample. We decided on a ‘wat-
chful waiting’ approach without specific treatment under a pre-
sumptive diagnosis of viral pericardiopleuritis. A follow-up 
chest radiography and echocardiography performed on the 6th 
hospital day showed near-resolution of the pericardiopleural 
effusion spontaneously. The patient was discharged 8 days 
after admission with symptomatic improvement. 
One month after discharge, however, the patient returned 
to our outpatient clinic complaining of recurrent chest pain 
with a dry cough and dyspnea. Chest radiography revealed 
the reappearance of a pleural effusion (Fig. 2A). We per-
formed a thoracentesis and pleural fluid analysis. The pleu-
ral fluid was yellow and contained 3,920/μL of red blood 
cells and 1,880/μL of WBCs (eosinophils accounted for 10% 
of all nucleated cells) (Fig. 2B). Protein and lactate dehydro-
genase in the pleural fluid and serum were 6.89 g/dL and 
389 IU/L, and 8.5 g/dL and 465 IU/L, respectively. Other pl-
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Fig. 1. Images obtained at the time of first admission. A: chest radiograph showed mild cardiomegaly without pulmonary congestion and blunt-
ing of the left costrophrenic angle. B and C: echocardiogram demonstrated pericardial effusion with a maximal depth of 12 mm without he-
modynamic significance. D: chest CT revealed pericardial effusion and a small amount of pleural effusion, but no other notable findings.
B
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eural fluid results were as follows: specific gravity, 1.015; glu-
cose, 171 mg/dL; and adenosine deaminase, 19 IU/L. The pl-
eural fluid smear with gram stain, culture, and cytologic ex-
amination failed to detect Mycobacterium tuberculosis, or-
dinary bacteria, or malignant cells. As the day progressed, her 
cough and dyspnea improved with symptomatic treatment 
and the pericardiopleural effusion decreased in amount sp-
ontaneously on follow-up chest radiograph and echocardio-
gram performed on the 6th hospital day (Fig. 2C and D). 
The patient was discharged 8 days after the 2nd admission 
without any medications. The cause of the recurrent and spon-
taneously-absorbed exudative pericardiopleural effusion re-
mained unclear. 
A chest radiography obtained 10 days after the 2nd dis-
charge from our institution showed an increased amount of 
pleural effusion again. Therefore, we planned video-assisted 
thoracic surgery to obtain pleura tissue and pericardium in 
an effort to determine the definitive cause of the recurrent pe-
ricardiopleural effusion. At the time of admission for sur-
gery, we again reviewed her recent medical history meticu-
lously, and found that she had eaten more than 30 raw frogs 
3 months previously (at the beginning of May 2005) because 
her neighbors had advised her that raw frog flesh was good 
for thyroid disease.
Tuberculosis or malignancies, as the common causes of 
pericardial effusions, were ruled out by pleural fluid analysis 
(vide supra). We then entertained the cause of the pericardial 
effusion with peripheral eosinophilia to a parasitic infection, 
such as sparganosis, based on her history of ingesting the raw 
flesh of frogs. According to the general method for diagnos-
ing human sparganosis, we rechecked the entire body for the 
presence of subcutaneous lumps or masses and searched for 
nodules in the pericardium or pleura by chest CT to establish 
the pathologic diagnosis. However, there was no evidence of 
masses or lumps. Therefore, we decided to perform an ELISA 
using sparganum antigen with a modified Voller’s method.
13) 
Briefly, microplates (Immuno Modules
TM; Nunc, Rochester, 
NY, USA) were coated with 5 μg/μL of sparganum antigens 
in carbonate buffer (pH 9.6) and probed with sera diluted to 
1 : 20 in phosphate buffered saline (pH 7.4) containing 0.5% 
skim milk and 0.05% Tween-20. To detect antibodies bound 
to antigen, peroxidase-conjugated goat anti-human IgG (Cap-
pel Co., Durham, NC, USA) was used diluted 1 : 1,000 in ph-
osphate buffered saline (pH 7.4). The substrate for the color 
reaction was 0.1% O-phenylenediamine and the reaction was 
stopped by adding 50 μL of 4M H2SO4. Absorbances (Abs) 
were recorded at 492 nm using a micro-ELISA reader (Lab-
systems, Helsnk: Finland). Anti-sparganum-specific IgG in 
Fig. 2. Images obtained during the second admission. A: chest radiography showed increased amounts of pleural effusion. B: increased num-
ber of eosinophils was observed in the pleural fluid (black arrows) (wright stain, ×1,000). C and D: follow-up echocardiogram and chest radio-
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serum by ELISA was significantly higher (Abs, mean±SD: 
0.911±0.03) than the normal control level (maximum cut off 
Abs value: 0.2). 
The patient was treated with 3 consecutive doses of prazi-
quantel (75 mg/kg/day). Six weeks after treatment, the am-
ount of pericardiopleural effusion had decreased markedly 
and the eosinophil count in the peripheral blood had return-
ed to the normal range (387/μL; 5.1% of total WBCs). 
Four years after praziquantel treatment, the patient had a 
WBC count of 5,910/μL with 2% eosinophils (118/μL). The 
serum anti-sparganum-specific IgG level was reduced mark-
edly to an Abs of 0.698 as compared with that of the initial 
diagnosis, but remained higher than the level of normal con-
trols. A chest radiography and echocardiography showed no 
evidence of a pericardiopleural effusion (Fig. 3). She has not 




Sparganosis is an infection caused by the plerocercoid lar-
vae of various diphyllobothroid tapeworms, including the ge-
nus Spirometra. Humans are accidental secondary interme-
diate hosts and can be infected through three possible routes. 
The most common route of infection in humans is drinking 
water contaminated with cyclops containing procercoids, 
which penetrate the intestinal wall and then move to muscles 
or subcutaneous tissues. The second route is the ingestion of 
raw or partially cooked flesh of fish, frogs, snakes, and chick-
ens containing plerocercoids, which may result in parasite mi-
gration through the intestinal wall. The third route is the po-
ultice application of water infested with cyclops containing 
procerciods to open wounds or sore eyes, which is a common 
route in southeast Asia.
3)14) Eating raw flesh of snakes or frogs 
is the most important and frequent route of infection in Far 
East Asia, especially in Japan and Korea. The reasons for con-
suming the raw flesh of these animals in Korea are to poten-
tiate masculine activity, obtain special nutrition, cure some 
diseases, survive in combat, and because the flesh is liked.
3) 
In this case, the patient ate raw frogs to treat her hypothy-
roidism. 
About 500 cases of human sparganosis have been report-
ed in the medical literature from diverse areas in the world. 
In Korea, most infections present as lumps in subcutaneous 
tissues or intermuscular fascia, which are commonly found 
in the abdominal wall, scrotum, lower extremities, and chest 
wall.
3)14)15) Sometimes, infections involve the orbits, urinary 
tract, or body cavities, such as the abdomen or vertebral ca-
nal.
16)17) However, only a few cases of pleural cavity involve-
ment have been reported (10 cases of pleural sparganosis 
manifested with pleural effusion in Japan and 3 cases of pleu-
ral sparganosis in Korea, including 1 case of empyema and 1 
case with a pleural nodule without a pleural effusion).
4-10) 
However, the manifestation with pericardial effusion is ex-
tremely rare, and has not been previously reported, although 
one autopsy case was reported in Japan that the larvae was 
observed in the outer surface of the pericardium. Therefore, 
this is the first case of recurrent exudative pericardiopleural 
effusion in a presumed case of human sparganosis. Almost 
all patients with pleural effusions related to sparganosis have 
had a history of raw flesh ingestion and complained of non-
specific symptoms, such as, malaise, dyspnea, and pleuritic 
chest pain.
4-10) These previous cases had no subcutaneous 
lumps and showed lymphodominant exudative pleural effu-
sions with eosinophilia and peripheral eosinophilia without 
significant leukocytosis, except for one case of an empyema. 
Our case had similar laboratory findings with the above cases. 
Although the diagnosis of human sparganosis is usually 
established by pathologic examinations of worms or eggs, di-
agnosis is almost impossible in cases of pericardial or pleural 
Fig. 3. (A) chest radiograph and (B) echocardiogram obtained 6 weeks after 3 consecutive doses of praziquantel showed no evidence of a 
pericardiopleural effusion.
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effusions without a pleural nodule. In such cases, immuno-
serologic methods, such as ELISA, can be helpful to diag-
nose sparganosis
18)19) based on positivity for parasite-specific 
IgG.
6)10) Similarly, no subcutaneous lumps or pericardiopleu-
ral nodules were observed in our case and the amount of peri-
cardial effusion was too small to obtain by pericardiocente-
sis initially, thus we could not help testing patient serum by 
ELISA to diagnose sparganosis as a possible cause of the re-
current pericardiopleural exudative effusion. According to 
the ELISA results of previous cases in our parasitology labo-
ratory, ELISA using the sera of patients with sparganosis con-
firmed by pathologic examination showed the absorbance 
range from 0.45-1.0, whereas from 0.05-0.2 in the healthy con-
trols. All patients with sparganosis showed cross-reactivity 
with Cysticercus cellulosae, with an abs ≥0.5 and there was no 
cross-reactivity with Clonorchis sinensis or Paragonimus wes-
termani (unpublished internal data). In this patient, ELISA 
using sparganum and Cysticercus cellulosae antigen showed 
an abs of 0.911 and 0.57, respectively, which meant positive 
cross-reactivity in these 2 parasitologic diseases, but the ELI-
SA using Clonorchis sinensis and Paragonimus westermani an-
tigens showed negative results. These results are in agreement 
with our previous internal data. The diagnosis of our patient 
is more likely sparganosis than cysticercosis because she had 
eaten raw frogs rather than raw pork and no enhancing cystic 
lesions were observed in diagnostic imaging modalities. Clo-
norchiasis and paragonimiasis were ruled out based on nega-
tive responses to skin tests, repeated stool examinations, and 
ELISA results. Furthermore, normal thyroid function tests and 
the maintenance of thyroxine treatment eliminated the pos-
sibility of a pericardial effusion related to thyroid disease.
The principle treatment of human sparganosis is surgical re-
moval; no medication has been proven to be an effective meas-
ure against sparganum.
20) Even though surgical removal is 
the definitive treatment, it cannot be applied in some condi-
tions, such as the pericardiopleural effusion associated with 
sparganosis without a pleural or pericardial nodule or lump. 
Some reports have advised that praziquantel is effective in pl-
eural sparganosis. Tanaka et al.
4) reported a case of pleural 
sparganosis successfully treated with praziquantel, and Ishii 
et al.
5) treated a case of eosinophilic pleuritis due to sparga-
nosis with 3 consecutive doses of praziquantel (75 mg/kg/day). 
After treatment, the anti-sparganum-specific antibody titer 
was decreased and the eosinophil count in peripheral blood 
returned to normal.
5) The surgical method was not a treat-
ment option in the present case because the patient did not 
have a subcutaneous lump or a pericardiopleural nodule. Th-
erefore, we prescribed 3 consecutive doses of praziquantel (75 
mg/kg/day), as in the aforementioned cases.
4)6) Six weeks lat-
er, the serum anti-sparganum specific antibody titer in our 
patient was decreased and the eosinophil count in the peri-
pheral blood had returned to normal. 
We continue to follow this patient biannually for subcuta-
neous manifestations or pericardiopleural effusions related 
with sparganosis, but no additional findings have been de-
tected in >4 years. We surmised that praziquantel converted 
the sparganosis from an active to a latent form of infection. 
Thus, we suggest that praziquantel is a therapeutic option for 
pericardial effusion related to sparganosis when the worms 
cannot be surgically removed. Although human sparganosis 
manifesting as a pericardial effusion is rare, it should be con-
sidered an important cause of eosinophilic pericardiopleural 
effusions.
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